ARCHER DANIELS MIDLAND CO
10-Q, 1997-02-13
FATS & OILS
Previous: APPLIED POWER INC, SC 13G/A, 1997-02-13
Next: ARTS WAY MANUFACTURING CO INC, SC 13G/A, 1997-02-13





     PAGE 1
                                
                          UNITED STATES
                                
               SECURITIES AND EXCHANGE COMMISSION
                                
                    WASHINGTON, D. C.  20549

                            FORM 10-Q
                                
[X]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES  EXCHANGE ACT OF 1934

For the quarterly period ended December 31, 1996

                               OR

[ ]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES   EXCHANGE ACT OF 1934

For the transition period from _______________ to
_________________________

Commission file number 1-44

                 ARCHER-DANIELS-MIDLAND COMPANY
     (Exact name of registrant as specified in its charter)

         Delaware                                  41-0129150
(State or other jurisdiction of                (I. R. S. Employer
incorporation or organization)                Identification No.)

4666 Faries Parkway   Box 1470   Decatur, Illinois   62525
(Address of principal executive offices)           (Zip Code)

Registrant's telephone number, including area code217-424-5200


Indicate by check mark whether the registrant (1) has filed
all reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the registrant was required
to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes _X_ No ___.

Indicate the number of shares outstanding of each of the
issuer's classes of common stock, as of the latest practicable
date.

         Common Stock, no par value--543,277,011 shares
                       (January 31, 1997)
1
     PAGE 2
PART I - FINANCIAL INFORMATION

         ARCHER DANIELS MIDLAND COMPANY AND SUBSIDIARIES
                                
               CONSOLIDATED STATEMENTS OF EARNINGS
                           (Unaudited)
<TABLE>
<CAPTION>

                                          THREE MONTHS ENDED
                                             DECEMBER 31,
                                      1996                  1995
                                      --------------------------
                                        (In thousands, except
                                          per share amounts)

<S>                                     <C>           <C>
Net sales and other operating income    $3,548,072   $3,415,05
                                                     8
Cost of products sold and other                      
operating
  costs                                 3,166,754    3,018,206
                                        _________    _________
                                                     
     Gross Profit                        381,318      396,852
                                                     
Selling, general and administrative      108,916      128,519
expenses
                                        _________    _________
                                                     
     Earnings From Operations            272,402      268,333
                                                     
Other income                              15,386       74,046
                                        _________    _________
                                                     
     Earnings Before Income Taxes        287,788      342,379
                                                     
Income taxes                              97,847      116,409
                                        _________    _________
                                                     
     Net Earnings                       $  189,941   $  225,97
                                                     0
                                        =========    =========
                                                     
                                                     
                                                     
Average number of shares outstanding     544,056      550,350
                                                     
Net earnings per common share                 $.35   
                                                     $.41
                                                     
Dividends per common share                    $.05   
                                                     $.048
</TABLE>

See notes to consolidated financial statements.

2
     PAGE 3
         ARCHER DANIELS MIDLAND COMPANY AND SUBSIDIARIES
                                
               CONSOLIDATED STATEMENTS OF EARNINGS
                           (Unaudited)

<TABLE>
<CAPTION>                                  SIX MONTHS ENDED
                                             DECEMBER 31,
                                      1996                 1995
                                      -------------------------
                                        (In thousands, except
                                          per share amounts)

<S>                                     <C>          <C>
Net sales and other operating income   $6,937,44    $6,535,79
                                       6            6
Cost of products sold and other                     
operating
   costs                               6,191,064    5,814,613
                                       _________    _________
                                                    
     Gross Profit                       746,382      721,183

                                                    
Selling, general and administrative                 
   expenses                             415,312     
                                                    227,240
                                       _________    _________
                                                    
     Earnings From Operations           331,070     
                                                    493,943
                                                    
Other income                             34,827     
                                                    95,561
                                       _________    _________
                                                    
     Earnings Before Income Taxes       365,897      589,504
                                                    
Income taxes                            172,403     
                                                    200,432
                                       _________    _________
                                                    
     Net Earnings                      $  193,49    $  389,07
                                       4            2
                                       =========    =========
                                                    
                                                    
Average number of shares outstanding    544,581      553,800
                                                    
Net earnings per common share                $            $
                                       .36          .70
                                                    
Dividends per common share                               $
                                       $.098        .071

</TABLE>
See notes to consolidated financial statements.
3
     PAGE 4
         ARCHER DANIELS MIDLAND COMPANY AND SUBSIDIARIES
                                
                   CONSOLIDATED BALANCE SHEETS
                           (Unaudited)

<TABLE>
<CAPTION>
                                       DECEMBER 31,    JUNE 30,
                                           1996          1996
                                       --------------------------
                                             (In thousands)

<S>                                     <C>          <C>
ASSETS                                                        
Current Assets                                                
    Cash and cash equivalents                   $            $
                                          337,254      534,702
    Marketable securities                 555,902      820,147
    Receivables                         1,306,209    1,131,591
    Inventories                         2,199,435    1,790,636
    Prepaid expenses                      135,778      107,607
                                        _________   __________
                                                _
                                                              
         Total Current Assets           4,534,578    4,384,683
                                                              
                                                              
Investments and Other Assets                                  
    Investments in and advances to                            
      affiliates                        1,008,763      624,305
    Long-term marketable securities       958,638    1,092,969
    Other assets                          217,750      233,611
                                        _________   __________
                                                _
                                                              
                                        2,185,151    1,950,885
                                                              
Property, Plant and Equipment                                 
     Land                                 115,627      114,542
     Buildings                          1,282,737    1,245,662
     Machinery and equipment            6,233,236    6,034,979
     Construction in progress             699,546      588,711
     Less allowances for                                       
depreciation                           (4,034,270    (3,869,593
                                                )             )
                                        _________   __________
                                                _
                                                              
                                        4,296,876    4,114,301
                                        _________   __________
                                                _
                                                              
                                        $11,016,6   $10,449,86
                                               05            9
                                        =========   ==========
                                                =
                                                              
                                                              

</TABLE>
See notes to consolidated financial statements.
4
     PAGE 5
         ARCHER DANIELS MIDLAND COMPANY AND SUBSIDIARIES

                   CONSOLIDATED BALANCE SHEETS
                           (Unaudited)


<TABLE>
<CAPTION>
                                         DECEMBER 31,   JUNE 30,
                                             1996         1996
                                        --------------------------
                                              (In thousands)

<S>                                        <C>          <C>
LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities
  Short-term debt                         $  171,914  $     -
  Accounts payable                       1,243,561      993,403
  Accrued expenses                         588,145      525,626
   Current maturities of long-term debt     126,957      114,522

                                        __________   __________

  Total Current Liabilities              2,130,577    1,633,551


Long-Term Debt                            1,984,735    2,002,979


Deferred Credits
  Income taxes                             564,867      562,362
  Other                                    106,194      106,165
                                        __________   __________


                                           671,061      668,527

Shareholders' Equity
  Common stock                           3,830,125    3,869,875
  Reinvested earnings                    2,400,107    2,274,937
                                        __________   __________

                                         6,230,232    6,144,812

                                        __________   __________

                                       $11,016,605  $10,449,869
                                        ==========   ==========
</TABLE>
See notes to consolidated financial statements.
5
     PAGE 6
          ARCHER DANIELS MIDLAND COMPANY AND SUBSIDIARIES
                                 
               CONSOLIDATED STATEMENTS OF CASH FLOWS
                            (Unaudited)
<TABLE>
<CAPTION>
                                              SIX MONTHS ENDED
                                                DECEMBER 31,
                                          1996               1995
                                          -----------------------
                                               (In thousands)
<S>                                                 <C>
<C>
Operating Activities                                              
 Net earnings                                         $           $
                                               193,494     389,072
  Adjustments to reconcile to net cash                             
    provided by operations                            
      Depreciation and amortization                215,135     194,407
      Deferred income taxes                        (24,350)     58,938
      Amortization of long-term debt discount       14,056      12,434
      (Gain) loss on marketable securities                            
        transactions                           (48,272)   (67,811)
      Other                                         14,177    (27,206)
      Changes in operating assets and                                 
liabilities
        Receivables                                 (159,998)   (92,723)
        Inventories                                 (405,795)  (891,458)
        Prepaid expenses                             (28,496)    (7,167)
        Accounts payable and accrued expenses         355,598    433,713
                                              ________    ________
                                                                  
        Total Operating Activities                   125,549       2,199
                                                                  
Investing Activities                                              
  Purchases of property, plant and equipment   (400,249)  (354,510)
  Business acquisitions                         (44,091)   (26,120)
  Investments in and advances to affiliates    (334,164)   (56,482)
  Purchases of marketable securities           (688,349)  (279,702)
  Proceeds from sales of marketable            1,105,500    965,659
securities
  Other                                               -     (1,241)
                                              ________    ________
                                                     _
                                                                  
        Total Investing Activities                  (361,353)    247,604
                                                                  
Financing Activities                                              
  Long-term debt borrowings                           -       6,305
  Long-term debt payments                       (18,024)    (8,434)
  Net borrowings under line of credit           171,914     296,336
agreements
  Purchases of treasury stock                   (63,212)  (187,948)
  Cash dividends and other                      (52,322)   (36,752)
                                              ________    ________
                                                     _
                                                                  
        Total Financing Activities                    38,356      69,507
                                              ________    ________
                                                     _
                                                                  
  Increase (Decrease) In Cash and Cash                             
Equivalents                                   (197,448)    319,310
Cash and Cash Equivalents Beginning of         534,702     454,593
Period
                                              ________    ________
                                                     _
                                                                  
  Cash and Cash Equivalents End of Period             $           $
                                               337,254     773,903
                                              ========    ========
                                                     =
</TABLE>
See notes to consolidated financial statements.
6
       PAGE 7
         ARCHER DANIELS MIDLAND COMPANY AND SUBSIDIARIES
                                
           NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                           (Unaudited)
                                
Note 1.The accompanying unaudited consolidated financial
       statements have been prepared in accordance with
       generally accepted accounting principles for interim
       financial information and with the instructions to Form
       10-Q and Article 10 of Regulation S-X. Accordingly, they
       do not include all of the information and footnotes
       required by generally accepted accounting principles for
       complete financial statements. In the opinion of
       management, all adjustments (consisting of normal
       recurring accruals) considered necessary for a fair
       presentation have been included. Operating results for
       the quarter and six months ended December 31, 1996 are
       not necessarily indicative of the results that may be
       expected for the year ending June 30, 1997.  For further
       information, refer to the consolidated financial
       statements and footnotes thereto included in the
       Company's annual report on Form 10-K for the year ended
       June 30, 1996.

Note 2.   Other Income

<TABLE>
<CAPTION>
                             THREE MONTHS ENDED SIX MONTHS ENDED
                               DECEMBER 31,       DECEMBER 31,
                             1996        1995   1996       1995
                           -------------------------------------
                              (In thousands)    (In thousands)
       <S>                   <C>       <C>      <C>     <C>
       Investment income  $ 30,348  $ 37,328  $ 69,215 $ 79,151
       Interest expense    (48,133)  (42,556)  (94,260)(82,633)
       Gain on marketable
        securities transactions17,983 67,181    48,284  67,869
       Equity in earnings of
        affiliates          13,666     8,936    11,675  13,343
       Other                 1,522     3,157       (87) 17,831
                            ______    ______    ______  ______

                          $ 15,386  $ 74,046    $34,827  $95,561
                              ======     ======  ======   ======
</TABLE>

Note 3.              Per Share Data

       All references to share and per share information have
       been adjusted for the 5 percent stock dividend paid
       September 16, 1996.


Note 4.Antitrust Investigation and Related Litigation

       A federal grand jury in the Northern District of
       Illinois has been conducting an investigation into
       possible violations by the Company of federal antitrust
       laws and related matters with respect to the sale of
       lysine, an amino acid feed additive used in poultry and
       swine feed.  A federal grand jury in  the Northern
       District of California has been investigating possible
       antitrust violations by the Company with respect to the
       sale of citric acid, an organic acid used in various
       foods, beverages and other products.  A federal grand
       jury in  the Northern District of Georgia has been
       investigating possible antitrust violations by the
       Company with respect to the sale of the Company's high
       fructose corn syrup product line.  Each of these
       investigations has been under the direction of the
       United States Department of Justice.  Two former
       executive officers of the Company, Michael D. Andreas
       and Terrance S. Wilson, have been indicted in connection
       with the lysine investigation.

       On October 15, 1996, the Company pled guilty to a two
       count information in the Northern District of Illinois
       pursuant to an agreement with the Department of Justice.
       This information states that the Company engaged in
       anticompetitive conduct in connection with the sale of
       lysine and citric acid.  In connection with its
       agreement the Company has paid the United States a fine
       of $70 million with respect to lysine and $30 million
       with respect to citric acid. This agreement constitutes
       a global resolution of all matters between the United
       States Department of Justice and the Company and brings
       to a close all Department of Justice investigations of
       the Company, including the federal grand jury's
       investigation with respect to high fructose corn syrup.

       Following public announcement in June 1995 of these
       investigations, the Company and certain of its directors
       and executive officers were named as defendants in a
       number of putative class action suits for alleged
       violations of federal securities laws on behalf of all
       purchasers of securities of the Company during the
       period between certain dates in 1992 and 1995.  The
       Company along with other domestic and foreign companies,
       has been named as a defendant in a number of putative
       class action antitrust suits involving the sale of
       lysine, citric acid, and high fructose corn syrup.  The
       plaintiffs generally request unspecified compensatory
       damages, costs, expenses and unspecified relief. The
       Company and the individuals named as defendants intend
       to vigorously defend these class actions unless they can
       be settled on terms deemed acceptable by the parties.
       These matters have resulted, as discussed below, and
       could result in the Company being subject to monetary
       damages, other sanctions and expenses.

       On July 20, 1996, Federal District Court Judge Milton
       Shadur approved a settlement in the federal lysine class
       action antitrust suit filed in the Northern District of
       Illinois (consolidated as In Re Amino Acid Lysine
       Antitrust Litigation MDL No. 1083) and the Company has
       paid $25 million in full settlement thereof without
       admitting the alleged violations of law.  Several
       plaintiffs  opted out of this settlement and numerous
       state class action antitrust cases involving the sale of
       lysine remain pending. A non-class action federal
       antitrust suit involving the sale of lysine which was
       filed in November 1995 and encaptioned Purina Mills,
       Inc. et al. v. Archer-Daniels-Midland Co. was
       subsequently consolidated with In Re Amino Acid Lysine
       Antitrust Litigation and the Company recently settled
       this action, including plaintiffs who opted out of or
       objected to the settlement noted above, for an amount
       deemed not material. On September 27, 1996, the Company
       entered into an agreement with counsel for the plaintiff
       class in the consolidated federal securities class
       action suit pending in the Central District of Illinois
       (G.M. Lawrence Limited Frozen Retirement Trust Dated
       September 1, 1992, et al. v. Archer-Daniels-Midland Co.,
       et al., Case Number 95-2287) in which among other
       things, the Company agreed to pay $30 million to members
       of the class without admitting
7
              PAGE 8

       the alleged violations of law.  The court has
       preliminary approved the settlement.  On September 27,
       1996, the Company entered into an agreement with counsel
       for the plaintiff class in the consolidated federal
       citric acid class action antitrust suit filed in the
       Northern District of California (consolidated as In Re
       Citric Acid Antitrust Litigation, MDL No. 1092, Marten
       File No. C-95-2963 (FMS)) in which among other things,
       the Company agreed to pay $35 million to members of the
       class without admitting the alleged violations of law.
       Formal papers seeking court approval of the settlement
       recently have been filed. The Company has also entered
       into settlement agreements  relating to certain state
       actions filed by indirect purchasers of lysine in which,
       among other things, the Company has agreed to pay
       amounts deemed not material to certain members of the
       class without admitting the alleged violations of law.

       The Company made a $200 million provision in the quarter
       ended September 30, 1996 to cover the fines, litigation
       settlements and related costs and expenses described
       above.  Such provision is reflected in the Company's
       first quarter selling, general and administrative
       expenses.  Because of the early stage of  other putative
       class actions, including those related to high fructose
       corn syrup, the ultimate outcome of these matters cannot
       presently be determined.  Accordingly, no provision for
       any liability that may result therefrom has been made in
       the unaudited consolidated financial statements.

       The Company and its directors also have been named as
       defendants in two putative class action suits, one of
       which alleges violations of Delaware state law and a
       similar case in District Court in Illinois which alleges
       violations of federal securities laws.  Both cases seek
       invalidation of the election of the Company's directors
       on the basis of alleged omissions from the proxy
       statement issued by the Company prior to its 1995 Annual
       Meeting of Shareholders.  The case relating to
       violations of Delaware law has been dismissed and is now
       on appeal in the Supreme Court of Delaware.  The case
       filed in Federal District Court in Illinois has likewise
       been dismissed and has been appealed to the Seventh
       Circuit Court of Appeals.  The Company and the
       individuals named as defendants intend to vigorously
       defend these actions.

       Shareholder derivative actions also have been filed
       against certain of the Company's directors and executive
       officers and nominally against the Company alleging that
       the individuals named as defendants breached their
       fiduciary duties to the Company and seeking monetary
       damages and other relief on behalf of the Company from
       the individuals named as defendants.  The Company has
       moved to dismiss  these derivative actions on the ground
       that they cannot be maintained unless the plaintiffs
       first brought their complaints to the Company's Board of
       Directors, which they did not.

       The Company from time to time, in the ordinary course of
       business, is named as a defendant in various other
       lawsuits.  In the Company's opinion, the gross liability
       from such other lawsuits, including environmental
       exposure, with or without insurance recoveries is not
       considered to be material to the Company's consolidated
       financial condition or results of operations.
     8
     PAGE 9
         ARCHER DANIELS MIDLAND COMPANY AND SUBSIDIARIES
                                
  MANAGEMENT'S DISCUSSION OF OPERATIONS AND FINANCIAL CONDITION

The Company is in one business segment - procuring,
transporting, storing, processing and merchandising agricultural
commodities and products.  The availability and price of
agricultural commodities are subject to wide fluctuations due to
unpredictable factors such as:  weather; plantings; government
(domestic and foreign) farm programs and policies; changes in
global demand created by population growth and higher standards
of living; and global production of similar and competitive
crops.  Generally, changes in the price of agricultural
commodities can be passed through to the price of processed
products.  Ethanol is one of a limited few of the Company's
processed products which must be priced to compete with products
produced from other raw materials. To reduce the price risk of
market fluctuations, the Company follows a policy of hedging
substantially all inventory and related purchase and sale
contracts.  In addition, the Company from time to time will
hedge portions of its anticipated production requirements. The
instruments used are principally readily marketable exchange
traded futures contracts which are designated as hedges.  The
changes in market value of such contracts have a high
correlation to the price changes of the hedged commodity.  Also,
the underlying commodity can be delivered against such
contracts.  To obtain a proper matching of revenue and expense,
gains or losses arising from open and closed hedging
transactions are included in inventory as a cost of the
commodities and reflected in the income statement when the
product is sold. Inflation, over time, has an impact on
agricultural commodity prices. The Company's business is capital
intensive and inflation could impact the cost of capital
investment.

OPERATIONS

Net sales and other operating income increased $133 million to
$3.5 billion for the quarter and increased $401 million to $6.9
billion for the six months due primarily to increases in average
selling prices of 5 percent and 9 percent, respectively. These
increases were partially offset by decreases in volume of
products sold of 1 percent for the quarter and 3 percent for the
six months. A summary of net sales and other operating income by
classes of products and services is as follows:

<TABLE>
<CAPTION>


                              THREE MONTHS        SIX MONTHS
                                  ENDED             ENDED
                              DECEMBER 31,       DECEMBER 31,
                             1996      1995     1996     1995
                             _______________    ______________
                             ___                ___
                              (In millions)     (In millions)
<S>                            <C>     <C>       <C>     <C>
 Oilseed products            $ 2,276  $ 2,07    $ 4,385 $ 3,929
                                      3
 Corn products                  596     674      1,165   1,290
 Wheat and other milled         424     429        874     831
 products
 Other products and             252     239        513     486
 services
                             ______   ______    ______  ______
                             $ 3,548  $ 3,41    $ 6,937 $ 6,536
                                      5
                             ======   ======    ======  ======
</TABLE>
9
     PAGE 10
Sales of oilseed products increased 10 percent for the quarter
and 12 percent for the six months due principally to higher
average selling prices reflecting the higher cost of raw
materials. Sales volumes of oilseed products were 4 percent
higher for the quarter and 1 percent higher for the six months
reflecting relatively strong protein meal demand from both the
domestic and export markets. Sales of corn products decreased
12 percent for the quarter and 10 percent for the six months
due primarily to decreased sales volumes of fuel alcohol as
reduced corn supplies and the resulting higher cost of corn
resulted in the Company reducing its grind. Average selling
prices of corn products were up 6 percent for both the quarter
and six month periods due to the good demand for the Company's
fuel, beverage and industrial alcohol as well as for the
Company's bioproducts, including lysine, threonine and MSG.
Sales of wheat and other milled products decreased 1 percent
for the quarter due principally to decreased sales volumes
reflecting reduced export flour demand and increased
production capacity in the industry. For the six month period,
sales of wheat and other milled products increased 5 percent
due principally to increased average selling prices reflecting
the higher cost of raw materials. This average selling price
increase was partially offset by decreased sales volumes.

Cost of products sold and other operating costs increased $149
million for the quarter to $3.2 billion and increased $376
million for the six months to $6.2 billion due primarily to
increased average raw material commodity prices and increased
energy costs. These price increases were partially offset by
the decrease in volume of product sold.

Gross profit declined $15 million to $381 million for the
quarter as lower merchandising margins combined with the
negative effect of increased energy costs on processing and
transportation margins more than offset the effect of higher
average selling prices versus increased raw material prices.
For the six months gross profit increased $25 million to $746
million due primarily to the effect of higher selling prices
versus increased raw material commodity prices partially
offset by decreased sales volumes, lower merchandising margins
and the negative effect of increased energy costs on
processing and transportation margins.

Selling, general and administrative expenses decreased $20
million to $109 million for the quarter due primarily to
decreased legal and litigation related expenses. For the six
months, selling, general and administrative expense increased
$188 million to $415 million due principally to increased
legal and litigation related costs including the $200 million
provision made in the first quarter of the fiscal year related
to fines and litigation settlements arising out of the United
States Department of Justice antitrust investigation of the
Company's lysine and citric acid products as well as a
securities suit brought by shareholders (see note 4).

The decrease in other income for the quarter and six months
was due principally to decreased gains on marketable
securities transactions. To a lesser extent, other income
decreased for the quarter and six months due to decreased
investment income due to both lower interest rates and lower
invested funds and increased interest expense due primarily to
lower amounts of interest capitalized on construction
projects. For the six months, the decrease in other income
reflects the prior year's $15 million gain on the sale of the
Company's Supreme Sugar subsidiary.

10
     PAGE 11
The decrease in income taxes for both the quarter and six
months resulted primarily from lower pretax earnings. For the
six months, this decrease was partially offset by a higher
effective income tax rate. The increase in the Company's
effective income tax rate to 47 percent for the six months
compared to an effective rate of 34 percent last year was due
primarily to the non-deductibility for income tax purposes of
a portion of the Company's litigation settlements and fines.
The Company's effective income tax rate of 34 percent for the
quarter was comparable to the same period a year ago.

LIQUIDITY AND CAPITAL RESOURCES

At December 31, 1996, the Company continued to show
substantial liquidity with working capital of $2.4 billion,
including cash and marketable securities net of short-term
debt of $721 million. Capital resources remained strong as the
Company's net worth at quarter-end was $6.2 billion. The
Company's ratio of long-term liabilities to total capital at
December 31, 1996 was approximately 22 percent.

As discussed in Note 4 to the unaudited consolidated financial
statements, various grand juries under the direction of the
United States Department of Justice have been conducting
investigations into possible violations by the Company of
federal antitrust laws and related matters with respect to the
sale of lysine, citric acid and high fructose corn syrup
product lines. Two former executive officers of the Company
have been indicted in connection with the lysine
investigation. On October 15, 1996, the Company pled guilty to
engaging in anticompetitive conduct in connection with the
sale of lysine and citric acid and agreed to pay the United
States $100 million in fines. The agreement brings to a close
all Department of Justice investigations against the Company,
including the investigation with respect to high fructose corn
syrup. In addition, related civil class actions have been
filed against the Company which could result in the Company
being subject to monetary damages, other sanctions and
expenses. As also discussed in note 4 to the unaudited
consolidated financial statements, the Company has agreed to
settle certain civil class action suits involving lysine
antitrust, citric acid antitrust and federal securities law
litigation. The Company made a $200 million provision in the
quarter ended September 30, 1996 sufficient to cover such
fines and settlements and related costs and expenses. Because
of the early stage of  other putative class actions, including
those related to high fructose corn syrup, the ultimate
outcome of these matters cannot presently be determined.
Accordingly, no provision for any liability that may result
therefrom has been made in the  unaudited consolidated
financial statements.

PART II - OTHER INFORMATION

     Item 1. Legal Proceedings

                       ENVIRONMENTAL MATTERS

     In 1993, the State of Illinois Environmental Protection
     Agency brought administrative enforcement proceedings
     arising out of the Company's failure to obtain permits
     for certain pollution control equipment at certain of the
     Company's processing facilities in Illinois.  The Company
     believes it has meritorious defenses.  In management's
     opinion these proceedings will not, either individually
     or in the aggregate, have a material adverse effect on
     the Company's financial condition or results of
     operations.

     The Company is involved in approximately 24
     administrative and judicial proceedings in which it has
     been identified as a potentially responsible party (PRP)
     under the federal Superfund law and its state analogs for
     the study and clean-up of sites contaminated by material
     discharged into the environment.  In all of these
     matters, there are numerous PRPs.  Due to various factors
     such as the required level of remediation and
     participation in the clean-up effort by others, the
     Company's future clean-up costs at these sites cannot be
     reasonably estimated.  However, in management's opinion
     these proceedings will not, either individually or in the
     aggregate, have a material adverse effect on the
     Company's financial condition or results of operations.

       LITIGATION REGARDING ALLEGED ANTICOMPETITIVE PRACTICES

     The Company and certain of its current and former
     officers and directors are currently defendants in
     various lawsuits related to alleged anticompetitive
     practices by the Company as described in more detail
     below.  The Company and the individual defendants named
     in these actions intend to vigorously defend the actions
     unless they can be settled on terms deemed acceptable to
     the parties.   The Company has paid and intends to
     continue to pay the legal expenses of its current and
     former officers and directors and to indemnify these
     persons with respect to these actions in accordance with
     Article X of the Bylaws of the Company.

     GOVERNMENTAL INVESTIGATIONS

     A federal grand jury in the Northern District of Illinois
     has been conducting an investigation into possible
     violations by the Company of federal antitrust laws and
     related matters with respect to the sale of lysine, an
     amino acid feed additive used in poultry and swine feed.
     A federal grand jury in  the Northern District of
     California has been investigating possible antitrust
     violations by the Company with respect to the sale of
     citric acid, an organic acid used in various foods,
     beverages and other products. A federal grand jury in
     the Northern District of Georgia has been investigating
     possible antitrust violations by the Company with respect
     to the sale of the Company's high fructose corn syrup
     product line.  Each of these investigations has been
     under the direction of the United States Department of
     Justice.  Two  former executive officers of the Company,
     Michael D. Andreas and Terrance S. Wilson,  have been
     indicted in connection with the lysine investigation.

     On October 15, 1996, the Company pled guilty to a two
     count information in the Northern District of Illinois
     pursuant to an agreement with the Department of Justice.
     This information states that the Company engaged in
     anticompetitive conduct in connection with the sale of
     lysine and citric acid.  In connection with its agreement
     the Company will pay the United States a fine of $70
     million with respect to lysine and $30 million with
     respect to citric acid.  This agreement constitutes a
     global resolution of all matters between the United
     States Department of Justice and the Company and brings
     to a close all Department of Justice
11
     PAGE 12
     Item 1.   Legal Proceedings--Continued

     investigations of the Company, including the federal
     grand jury's investigation with respect to high fructose
     corn syrup.

     The Company's agreement with the Department of Justice
     further obligates the Company to cooperate with the
     government's continued investigation with respect to
     possible violations by others of federal antitrust laws
     and related matters in the food additives industry.
     Under the agreement, the Department of Justice agrees not
     to bring any action against any director, officer or
     employee of the Company (or its subsidiaries or
     affiliates), other than Michael D. Andreas and Terrance
     S. Wilson, involving the sale or production of any
     product sold or produced by the Company's BioProducts
     Division, Animal Health and Nutrition Division, Food
     Additives Division, or Sweetener Group or for any action
     which  was or is the subject of pending investigations in
     the Central District of Illinois and the Southern
     District of Alabama. Mr. Andreas, who no longer serves as
     an officer of the Company, requested and was granted a
     temporary administrative leave from the Company.  Mr.
     Wilson has retired from the Company for medical reasons.
     There is no understanding or agreement as to what
     position, if any, Mr. Andreas may return to at the
     Company.

     As part of the agreement, the United States agreed not to
     bring further criminal charges against the Company or any
     of its subsidiaries or affiliates for any offense
     committed prior to the date of the agreement that was
     undertaken in furtherance of or in connection with any
     attempted or completed antitrust conspiracy involving the
     sale or production of any product by the Company's
     BioProducts Division, Animal Health and Nutrition
     Division, Food Additives Division, or Sweetener Group, or
     for any alleged offense which is or was the subject of
     any pending investigation of ADM.  Although the immunity
     agreement excepted any criminal violations of the federal
     tax law from its scope, the agreement represented that
     ADM was not a subject of the investigation being
     conducted by the Fraud Section of the Criminal Division
     of the Department of Justice. The government further
     agreed not to prosecute any current officer, director, or
     employee of the Company or any of its subsidiaries or
     affiliates (other than Michael D. Andreas and Terrance S.
     Wilson) for any of the antitrust matters set forth above
     or for any alleged misappropriation of technology
     committed prior to the date of the agreement.  The
     Company also agreed to cooperate with the government's
     investigations by: (i) providing non-privileged
     documents, information, and other materials; and (ii)
     securing, using its best efforts, the cooperation of any
     current director, officer, or employee of the company or
     its subsidiaries or affiliates (other than Michael D.
     Andreas and Terrance S. Wilson) for service of process,
     interviews, grand jury testimony, and trial testimony.
     The agreement also provided that if any current officer,
     director or employee failed to comply with the
     cooperation obligations as specified, the agreement not
     to prosecute those
12
     PAGE 13
     Item 1.   Legal Proceedings--Continued

     persons would be void.  The full details of the plea
     agreement and the Company's cooperation obligations
     thereunder are set forth in the agreement, which is a
     matter of public record in 96-CR-00640.

     On February 12, 1997 the Company's three Mexican
     subsidiaries each received notice that the Mexican
     Federal Competition Commission has commenced an
     investigation in order to determine if, as a result of
     the Company's guilty plea in the United States,
     violations of the Mexican Federal Anti-trust Law have
     been committed relative to the marketing and sale of
     lysine in Mexico.

     SECURITIES LAWS CLASS ACTION

     Following public announcement in June 1995 of the
     government's antitrust investigation, the Company and
     certain of its then current directors and executive
     officers were named as defendants in seventeen putative
     class action suits filed on behalf of all purchasers of
     securities of the Company during the period between
     certain dates in 1992 and 1995. Fourteen of these suits
     were consolidated under the name In Re Archer-Daniels-
     Midland Company Securities Litigation, United States
     District Court, Northern District of Illinois, Civil
     Action No. 95-C-3979, and a consolidated complaint was
     filed on September 22, 1995. The consolidated complaint
     alleges that the defendants made material
     misrepresentations and omissions with respect to the
     Company and its operations and with respect to actions of
     the Company and its officers regarding  antitrust
     violations, as a result of which market prices of the
     Company's securities were artificially inflated during
     the putative class period. The consolidated complaint
     alleges that the conduct complained of violates federal
     securities laws. The plaintiffs request unspecified
     compensatory damages, costs (including attorneys and
     expert fees), expenses and other unspecified relief on
     behalf of the putative class. On October 31, 1995, the
     Court granted the defendants' motion to transfer the
     consolidated action to the Central District of Illinois
     (wherein it now bears the caption E. M. Lawrence Limited
     Frozen Retirement Trust Dated September 1, 1992, et al.
     v. Archer-Daniels-Midland Co., et al., Case Number 95-
     2287).  The three remaining actions, which originally
     were filed in the Central District of Illinois, also have
     been consolidated as part of the E.M. Lawrence Limited
     Frozen Retirement Trust Dated September 1, 1992, et al.
     v. Archer Daniels Midland Co., et al., action.  The
     Company and the individual defendants  moved to dismiss
     this consolidated  action. On September 27, 1996, the
     Company entered into an agreement with counsel for the
     plaintiff class in which among other things, the Company
     agreed to pay $30 million to members of the class,
     without admitting the alleged violations of law.  The
     court has preliminary approved the settlement.  Notice is
     being sent to members of the plaintiff class at this
     time, and a final approval hearing has been scheduled for
     April 11, 1997.
13
     PAGE 14
     Item 1.   Legal Proceedings--Continued

     HIGH FRUCTOSE CORN SYRUP ACTIONS

     The Company, along with other companies, has been named
     as a defendant in  thirty antitrust suits involving the
     sale of high fructose corn syrup.   Twenty-nine of these
     actions have been brought as putative class actions.

     FEDERAL ACTIONS.    Twenty-two of  these putative class
     actions allege violations of federal antitrust laws,
     including allegations that the defendants agreed to fix,
     stabilize and maintain at artificially high levels the
     prices of high fructose corn syrup, and seek injunctions
     against continued alleged illegal conduct, treble damages
     of an unspecified amount, attorneys fees and costs, and
     other unspecified relief. The putative classes in these
     cases comprise certain direct purchasers of high fructose
     corn syrup during certain periods in the 1990s.  These
     twenty-two actions have been transferred to the United
     States District Court for the Central District of
     Illinois and consolidated under the caption In Re High
     Fructose Corn Syrup Antitrust Litigation, MDL No. 1087
     and Master File No. 95-1477.  The parties are in the
     midst of discovery in this action.

     On January 14, 1997, the Company, along with other
     companies, was named a defendant in a non-class action
     antitrust suit involving the sale of high fructose corn
     syrup and corn syrup.  This action alleges violations of
     federal antitrust laws and Oregon and Michigan state
     antitrust laws, including allegations that defendants
     conspired to fix, raise, maintain and stabilize the price
     of corn syrup and high fructose corn syrup, and seeks
     treble damages, attorneys' fees and costs of an
     unspecified amount.  The Company has not yet filed a
     responsive pleading.

      STATE ACTIONS.   The Company, along with other
     companies, also has been named as a defendant in six
     putative class action antitrust suits filed in California
     state court  involving the sale of high fructose corn
     syrup. These California actions allege violations of the
     California antitrust and unfair competition laws,
     including allegations that the defendants agreed to fix,
     stabilize and maintain at artificially high levels the
     prices of high fructose corn syrup, and seek treble
     damages of an unspecified amount, attorneys fees and
     costs, restitution and other unspecified relief.  One of
     the California putative classes comprise certain direct
     purchasers of high fructose corn syrup in the State of
     California during certain periods in the 1990s.  This
     action was filed on October 17, 1995 in Superior Court
     for the County of Stanislaus, California and encaptioned
     Kagome Foods, Inc. v Archer-Daniels-Midland Co. et al.,
     Civil Action No. 37236. This action has been removed to
     federal court and consolidated with the federal class
     action litigation pending in the Central District of
     Illinois referred to above.  The other five California
     putative classes comprise certain indirect purchasers of
     high fructose corn syrup in the State of California
     during certain periods in the 1990s. One such action was
     filed on July 21, 1995 in the Superior Court of the
     County of Los Angeles, California and is encaptioned
     Borgeson v. Archer-Daniels-Midland Co., et al., Civil
     Action No. BC131940. This action and the other four
     indirect purchases actions have been coordinated before a
     single court in Stanislaus County, California.  The other
     four actions are encaptioned, Goings v. Archer Daniels
     Midland Co., et al., Civil Action No. 750276 (Filed on
     July 21, 1995, Orange County Superior Court); Rainbow
     Acres v. Archer Daniels Midland Co., et al., Civil Action
     No. 974271 (Filed on November 22, 1995, San Francisco
     County Superior Court); Patane v. Archer Daniels Midland
     Co., et al., Civil Action No. 212610 (Filed on January
     17, 1996, Sonoma County Superior Court); and St. Stan's
     Brewing Co. v. Archer Daniels Midland Co., et al., Civil
     Action No. 37237 (Filed on October 17, 1995, Stanislaus
     County Superior Court).

     The Company, along with other companies, also has been
     named a defendant in a putative class action antitrust
     suit filed in Alabama state court.  The Alabama action
     alleges violations of the Alabama, Michigan and Minnesota
     antitrust laws, including allegations that defendants
     agreed to fix, stabilize and maintain at artificially
     high levels the prices of high fructose corn syrup, and
     seeks an injunction against continued illegal conduct,
     damages of an unspecified amount, attorneys fees and
     costs, and other unspecified relief. The putative class
     in the Alabama action comprises certain indirect
     purchasers in Alabama, Michigan and Minnesota during the
     period March 18, 1994 to March 18, 1996. This action was
     filed on March 18, 1996 in the Circuit Court of Coosa
     County, Alabama, and is encaptioned Caldwell v. Archer-
     Daniels-Midland Co., et al., Civil Action No. 96-17.  On
     April 22, 1996, defendants moved to sever the non-Alabama
     claims and have them dismissed.  This motion is still
     pending.
     14

     PAGE 15
     Item 1.   Legal Proceedings--Continued

     LYSINE CLASS ACTION

     The Company, along with other companies, has been named
     as a defendant in   twenty-one putative class action
     antitrust suits involving the sale of lysine.

     FEDERAL ACTIONS.  Six of these actions allege violations
     of federal antitrust laws, including allegations that
     certain entities agreed to fix, stabilize and maintain at
     artificially high levels the price of lysine, and seek
     injunctions against continued alleged illegal conduct,
     treble damages of an unspecified amount, attorneys fees
     and costs, and other unspecified relief. The putative
     classes in these cases comprise certain direct purchasers
     of lysine for certain periods in the 1990s.   These six
     actions were transferred to the United States District
     Court for the Northern District of Illinois and
     consolidated  under the caption In Re Amino Acid Lysine
     Antitrust Litigation, MDL No. 1083 and Master File No. 95-
     7679. On April 4, 1996, the Company executed a settlement
     agreement with counsel for the plaintiff class in which,
     among other things, the Company agreed to pay $25 million
     to members of the class, without admitting the alleged
     violations of law.  Several plaintiffs opted out of this
     settlement. This settlement agreement  was approved by
     the court and certain objectors to the settlement
     appealed the final order of approval to the United States
     Court of Appeals for the Seventh Circuit.  That appeal
     subsequently was dismissed.

     The Company, along with other companies also  was named
     as a defendant in one non-class action federal antitrust
     suit involving the sale of lysine. This action was filed
     on November 13, 1995 in the United States District Court
     for the Eastern District of Missouri and is encaptioned
     Purina Mills, Inc., et al. v Archer-Daniels-Midland Co.,
     Civil Action No. 95-CV-2227. It alleges violations of
     federal antitrust laws, including allegations that
     certain entities agreed to fix, stabilize and maintain at
     artificially high levels the price of lysine, and seeks
     an injunction against continued alleged illegal conduct,
     treble damages of an unspecified amount, attorneys fees
     and costs, and other unspecified relief.  This action was
     subsequently consolidated with In Re Amino Acid Lysine
     Antitrust Litigation and the Company recently settled
     this action, including plaintiffs who opted out of or
     objected to the settlement noted above, for an amount
     deemed not material.

     The Company, along with other companies, also has been
     named a defendant in a nationwide federal class action
     brought on behalf of consumers of certain poultry
     products during the period 1992 through 1996.  This
     action alleges violations of the federal antitrust laws,
     including allegations that the defendants unlawfully
     fixed the price of lysine, and requests $300 million in
     treble damages. On January 17, 1997, the court dismissed
     the action without prejudice after plaintiff requested a
     voluntary dismissal. This action is encaptioned Silvious
     v. Archer-Daniels-Midland Co., et al., No. 96-0128(H) and
     was filed on November 18, 1996 in federal court in the
     Western District of Virginia.


     15

     PAGE 16
     Item 1.   Legal Proceedings--Continued

     STATE ACTIONS.   The Company also has been named as a
     defendant, along with other companies, in six putative
     class action antitrust suits filed in California state
     court, two putative class action antitrust suits filed in
     Alabama state court, two putative class action antitrust
     suits filed in Minnesota state court, one putative class
     action antitrust suit filed in Georgia state court, one
     putative class action antitrust suit filed in Tennessee
     state court and   two putative class action antitrust
     suits filed in Michigan state court involving the sale of
     lysine. The California actions allege violations of the
     California antitrust and unfair competition laws,
     including allegations that the defendants agreed to fix,
     stabilize and maintain at artificially high levels the
     prices of lysine, and seek treble damages of an
     unspecified amount, attorneys fees and costs, restitution
     and other unspecified relief. The putative classes in the
     California actions comprise certain indirect purchasers
     of lysine in the State of California during certain
     periods in the 1990s.   These six actions were
     consolidated before the Superior Court for San Francisco
     County under the caption Feedstuffs Processing Co. v.
     Archer Daniels Midland Co, et al., Case No. 974597.  The
     Company has entered into an agreement with plaintiffs'
     counsel in  these California  actions, in which among
     other things, the Company agreed to pay $500,000 to
     certain members of the class, without admitting the
     alleged violations of law.  This settlement has received
     final  court approval. The two Alabama actions allege
     violations of the Alabama antitrust laws, including
     allegations that the defendants agreed to fix, stabilize
     and maintain at artificially high levels the prices of
     lysine, and seek an injunction against continued alleged
     illegal conduct, damages of an unspecified amount,
     attorneys fees and costs, and other unspecified relief.
     The putative classes in the Alabama actions comprise
     certain indirect purchasers of lysine in the State of
     Alabama during certain periods in the 1990s. One such
     action was filed on August 17, 1995 in the Circuit Court
     of DeKalb County, Alabama, and is encaptioned Ashley v.
     Archer-Daniels-Midland Co., et al., Civil Action No. 95-
     336.  The parties are in the midst of discovery in this
     action.  The other Alabama action, encaptioned Bailey v.
     Archer Daniels Midland Co., et al., Civil Action No. 95-
     165, and filed on December 11, 1995 in the Circuit Court
     of Tallapoosa County, has been placed on the court's
     administrative docket pending the outcome of the Ashley
     action.  One Minnesota action alleges violations of
     certain laws of the states of Minnesota, Tennessee,
     Wisconsin, South Dakota, North Dakota, Kansas, Louisiana,
     Michigan, Maine, Arizona, Florida, Mississippi, New
     Mexico, North Carolina and West Virginia, and the
     District of Columbia,  including allegations that
     defendants conspired to maintain the price of lysine at
     artificially high levels, and seeks treble damages of an
     unspecified amount, attorneys fees and costs, and other
     unspecified relief. The putative class in this action
     comprises certain indirect purchasers in the
     aforementioned states of lysine during the period June 1,
     1992 through April 19, 1996. This action was filed on
     April 10, 1996 in the District Court for Renville County,
     Minnesota and is encaptioned Big Valley Milling, Inc. v.
     Archer-Daniels-Midland Co., et al., No. C7-96-260. The
     other Minnesota action, encaptioned, United Mills v.
     Archer-Daniels-Midland Co., et al., No. 65-C2-96-215, and
     filed in the same court, seeks identical relief on behalf
     of certain indirect purchasers of lysine in all of the
     aforementioned states. On September 30, 1996, the Company
     moved to dismiss the non-Minnesota claims in the two
     Minnesota actions and moved for summary judgment on all
     claims in these actions. That motion is currently
     pending. On February 5, 1997, the Company entered into an
     agreement with plaintiffs' counsel in the Minnesota
     actions, in which among other things, the Company agreed
     to pay $1 million to certain members of the putative
     classes, without admitting the alleged violations of law.
     The parties are in the process of obtaining court
     approval of this agreement. The Georgia action,
     encaptioned Long v. Archer-Daniels-Midland Co., et al.,
     Civil Action No. E-43829, and filed on December 13, 1995
     in Fulton County Superior Court, alleges a restraint of
     trade in violation of Georgia common law and the Georgia
     state RICO act. This action includes allegations that the
     defendants conspired to maintain the price of lysine at
     artificially high levels and seeks an injunction against
     continued illegal conduct, treble damages of an
     unspecified amount, punitive damages attorneys fees and
     costs, and other unspecified relief. The putative class
     in the action comprises certain indirect purchasers of
     lysine in the state of Georgia during the period January
     1, 1990 until the present. On December 19, 1996, the
     Court granted the Company's motion to dismiss this
     action. The Tennessee action, encaptioned McCormack Farms
     v. Archer Daniels Midland Co., et al., Civil Action No.
     96C-2190, and filed on June 11, 1996 in Davidson County
     Circuit Court, alleges a restraint of trade in violation
     of the Tennessee Trade Practices Act and Tennessee
     Consumer Protection Act. This action includes allegations
     that defendants conspired to fix, maintain or stabilize
     the prices of lysine and seeks an injunction against
     continued illegal conduct, treble damages of an
     unspecified amount, attorneys' fees and costs, and other
     unspecified relief. The putative class in this case
     comprises certain indirect purchasers of lysine within
     the State of Tennessee during the period June 10, 1992
     through June 10, 1996.  The Company has not yet filed a
     responsive pleading.   The Michigan actions allege a
     restraint of trade in violation of the Michigan Antitrust
     Reform Act and include allegations that defendants
     conspired to fix, raise, maintain and stabilize the price
     of lysine and seeks an injunction against continued
     illegal conduct, treble damages of an unspecified amount,
     attorneys' fees and costs, and other unspecified relief.
     The putative classes in  these cases comprise certain
     indirect purchasers of lysine within the State of
     Michigan during  certain periods in the 1990s.  One such
     action, encaptioned Michigan Pork Producers Assn, et al.
     v. Archer Daniels Midland Co., et al., No. 906-10696-CZ,
     was filed on September 25, 1996 in Kent County Circuit
     Court. The second action, encaptioned Bacon Acres v.
     Archer Daniels Midland Co., et al., No P23920, was filed
     on September 24, 1996 in the Circuit Court for the County
     of Washtenaw, Michigan. The Company has not yet filed a
     responsive pleading in either action.
     16
     PAGE 17
     Item 1.   Legal Proceedings--Continued

     CITRIC ACID CLASS ACTIONS
     The Company, along with other companies, has been named
     as a defendant in  ten putative class action antitrust
     suits involving the sale of citric acid.

     FEDERAL ACTIONS.    Six of these actions allege
     violations of federal antitrust laws, including
     allegations that the defendants agreed to fix, stabilize
     and maintain at artificially high levels the prices of
     citric acid, and seek injunctions against continued
     alleged illegal conduct, treble damages of an unspecified
     amount, attorneys fees and costs, and other unspecified
     relief. The putative classes in these cases comprise
     certain direct purchasers of citric acid for certain
     periods in the 1990s.      These six actions have been
     transferred to  the United States District Court for the
     Northern District of California and consolidated as In Re
     Citric Acid Antitrust Litigation, MDL No. 1092, Master
     File No. C-95-2963(FMS). On September 27, 1996 the
     Company entered into an agreement with counsel for the
     plaintiff class in this consolidated action in which
     among other things, the Company agreed to pay $35 million
     to members of the class, without admitting the alleged
     violations of law.  Formal papers seeking court approval
     of the settlement  recently have been filed.

     STATE ACTIONS.   The Company, along with other companies,
     also has been named as a defendant in one putative class
     action antitrust suit filed in Alabama state court
     involving the sale of citric acid. This action alleges
     violations of the Alabama antitrust laws, including
     allegations that the defendants agreed to fix, stabilize
     and maintain at artificially high levels the prices of
     citric acid, and seeks an injunction against continued
     alleged illegal conduct, damages of an unspecified
     amount, attorneys fees and costs, and other unspecified
     relief. The putative class in the Alabama action
     comprises certain indirect purchasers of citric acid in
     the State of Alabama from July 1993 until July 1995. This
     action was filed on July 27, 1995 in the Circuit Court of
     Walker County, Alabama and is encaptioned Seven Up
     Bottling Co. of Jasper, Inc. v. Archer-Daniels-Midland
     Co., et al., Civil Action No. 95-436.  The Company
     currently is seeking appellate review of the denial of
     its motion to dismiss this action.  The Company, along
     with other companies, also has been named as a defendant
     in two putative class action antitrust suits filed in
     California state court involving the sale of citric acid.
     These actions allege violations of the California
     antitrust and unfair competition laws, including
     allegations that the defendants conspired to fix,
     maintain or stabilize the price of citric acid, and seek
     injunctions against continued illegal conduct, treble
     damages of an unspecified amount, attorneys fees and
     costs, and other unspecified relief. The putative classes
     in these cases comprise certain indirect purchasers of
     citric acid within the State of California during certain
     periods in the 1990s. One such action was filed on June
     12, 1996 in the Superior Court of the County of San
     Francisco, California and is encaptioned Bianco v. Archer
     Daniels Midland Co., et al., Civil Action No. 978912.
     The second action was filed on June 28, 1996 in San
     Francisco County Superior Court and is encaptioned
     Wignall v. Archer Daniels Midland Co., et al., Civil
     Action No. 979360. These actions recently have been
     coordinated before a single court in San Francisco,
     County, California.  The Company, along with other
     companies, also has been named as a defendant in one
     putative class action antitrust suit filed in Wisconsin
     state court involving the sale of citric acid.  This
     action alleges violations of the laws of Wisconsin,
     Minnesota, Alabama, Arizona, California, District of
     Columbia, Florida, Tennessee, West Virginia, Mississippi
     New Mexico, North Carolina, South Dakota, North Dakota,
     Kansas, Louisiana, Michigan and Maine, including
     allegations that defendants conspired to maintain the
     price of citric acid at artificially high levels and
     seeks injunctive relief, treble damages of an unspecified
     amount, attorneys fees and costs and other unspecified
     relief.  The putative class in this case comprises
     certain indirect purchasers of citric acid in the above
     referenced states during the period July 1, 1991 through
     June 27, 1995.  This action was filed on December 20,
     1996 in the Circuit Court for Milwaukee County, Wisconsin
     and is encaptioned Raz, et al. v. Archer-Daniels-Midland
     Co., et al., No.[]
     17
     PAGE 18
     Item 1.   Legal Proceedings --Continued

     HIGH FRUCTOSE CORN SYRUP/CITRIC ACID STATE CLASS ACTIONS

     The Company, along with other companies, has been named
     as a defendant in six putative class action antitrust
     suits involving the sale of both high fructose corn syrup
     and citric acid. Two of these actions allege violations
     of the California antitrust and unfair competition laws,
     including allegations that the defendants agreed to fix,
     stabilize and maintain at artificially high levels the
     prices of high fructose corn syrup and citric acid, and
     seek treble damages of an unspecified amount, attorneys
     fees and costs, restitution and other unspecified relief.
     The putative class in one of these California cases
     comprises certain direct purchasers of high fructose corn
     syrup and citric acid in the State of California during
     the period January 1, 1992 until at least October 1995.
     This action was filed on October 11, 1995 in the Superior
     Court of Stanislaus County, California and is entitled
     Gangi Bros. Packing Co. v. Archer-Daniels-Midland Co., et
     al., Civil Action No. 37217. The putative class in the
     other California case comprises certain indirect
     purchasers of high fructose corn syrup and citric acid in
     the state of California during the period October 12,
     1991 until November 20, 1995. This action was filed on
     November 20, 1995 in the Superior Court of San Francisco
     County and is encaptioned MCFH, Inc. v. Archer-Daniels-
     Midland Co., et al., Civil Action No. 974120. The
     California Judicial Council has bifurcated the citric
     acid and high fructose corn syrup claims in these actions
     and coordinated them with other actions in San Francisco
     County Superior Court and Stanislaus County Superior
     Court. The Company, along with other companies, also has
     been named as a defendant in at least one putative class
     action antitrust suit filed in West Virginia state court
     involving the sale of high fructose corn syrup and citric
     acid. This action also alleges violations of the West
     Virginia antitrust laws, including allegations that the
     defendants agreed to fix, stabilize and maintain at
     artificially high levels the prices of high fructose corn
     syrup and citric acid, and seeks treble damages of an
     unspecified amount, attorneys fees and costs, and other
     unspecified relief. The putative class in the West
     Virginia action comprises certain entities within the
     State of West Virginia that purchased products containing
     high fructose corn syrup and/or citric acid for resale
     from at least 1992 until 1994. This action was filed on
     October 26, 1995, in the Circuit Court for Boone County,
     West Virginia, and is encaptioned Freda's v. Archer-
     Daniels-Midland Co., et al., Civil Action No. 95-C-125.
     The parties are in the midst of discovery in this action.
     The Company, along with other companies, also has been
     named as defendant in  a putative class action antitrust
     suit filed in Michigan state court involving the sale of
     high fructose corn syrup and citric acid. This action
     alleges violations of the Michigan antitrust laws,
     including allegations that the defendants agreed to fix,
     stabilize and maintain at artificially high levels the
     prices of high fructose corn syrup and citric acid, and
     seeks treble damages of an unspecified amount, attorneys
     fees and costs, and other unspecified relief. The
     putative class in the Michigan action comprises certain
     persons within the State of Michigan that purchased
     products containing high fructose corn syrup and/or
     citric acid during the period January 1992 through
     February 26, 1996. This action was filed on February 26,
     1996 in the Circuit Court for Ingham County, Michigan,
     and is encaptioned Wilcox v. Archer-Daniels-Midland Co.,
     et al., Civil Action No. 96-82473-CP. The parties are in
     the midst of discovery in this action.  The Company,
     along with other companies, also has been named as a
     defendant in  a putative class action antitrust suit
     filed in the Superior Court for the District of Columbia
     involving the sale of high fructose corn syrup and citric
     acid. This action alleges violations of the District of
     Columbia antitrust laws, including allegations that the
     defendants agreed to fix, stabilize and maintain at
     artificially high levels the prices of high fructose corn
     syrup and citric acid, and seeks treble damages of an
     unspecified amount, attorneys fees and costs, and other
     unspecified relief. The putative class in the District of
     Columbia action comprises certain persons within the
     District of Columbia that purchased products containing
     high fructose corn syrup and/or citric acid during the
     period January 1, 1992 through December 31, 1994. This
     action was filed on April 12, 1996 in the Superior Court
     for the District of Columbia, and is encaptioned Holder
     v. Archer-Daniels-Midland Co., et al., Civil Action No.
     96-2975.  The parties are in the midst of discovery in
     this action.  The Company, along with other companies,
     has been named as a defendant in at least one putative
     class action antitrust suit filed in Kansas state court
     involving the sale of high fructose corn syrup and citric
     acid. This action alleges violations of the Kansas
     antitrust laws, including allegations that the defendants
     agreed to fix, stabilize and maintain at artificially
     high levels the prices of high fructose corn syrup and
     citric acid, and seeks treble damages of an unspecified
     amount, court costs and other unspecified relief. The
     putative class in the Kansas action comprises certain
     persons within the State of Kansas that purchased
     products containing high fructose corn syrup and/or
     citric acid during at least the period January 1, 1992
     through December 31, 1994. This action was filed on May
     7, 1996 in the District Court of Wyandotte County, Kansas
     and is encaptioned Waugh v. Archer-Daniels-Midland Co.,
     et al., Case No. 96-C-2029.  The parties are in the midst
     of discovery in this action.
     18
     PAGE 19
     Item 1.   Legal Proceedings--Continued

     HIGH FRUCTOSE CORN SYRUP/CITRIC ACID/LYSINE STATE CLASS
     ACTIONS

     The Company, along with other companies,  has been named
     as a defendant in six putative class action antitrust
     suits filed in California state court involving the sale
     of high fructose corn syrup, citric acid and/or lysine.
     These actions allege violations of the California
     antitrust and unfair competition laws, including
     allegations that the defendants agreed to fix, stabilize
     and maintain at artificially high levels the prices of
     high fructose corn syrup, citric acid and/or lysine, and
     seek treble damages of an unspecified amount, attorneys
     fees and costs, restitution and other unspecified relief.
     One of the putative classes comprises certain direct
     purchasers of high fructose corn syrup, citric acid
     and/or lysine in the State of California during a certain
     period in the 1990s. This action was filed on December
     18, 1995 in the Superior Court for Stanislaus County,
     California and is encaptioned Nu Laid Foods, Inc. v.
     Archer-Daniels-Midland Co., et al., Civil Action No.
     39693. The other five putative classes comprise certain
     indirect purchasers of high fructose corn syrup, citric
     acid and/or lysine in the State of California during
     certain periods in the 1990s. One such action was filed
     on December 14, 1995 in the Superior Court for Stanislaus
     County, California and is encaptioned Batson v. Archer-
     Daniels-Midland Co., et al., Civil Action No. 39680. The
     other actions are encaptioned Nu Laid Foods, Inc. v.
     Archer Daniels Midland Co., et al., No 39693 (Filed on
     December 18, 1995 Stanislaus County Superior Court);
     Abbott v. Archer Daniels Midland Co., et al., No. 41014
     (Filed on December 21, 1995, Stanislaus County Superior
     Court); Noldin v. Archer Daniels Midland Co., et al., No.
     41015 (Filed on December 21, 1995, Stanislaus County
     Superior Court); Guzman v. Archer Daniels Midland Co., et
     al., No. 41013 (Filed on December 21, 1995, Stanislaus
     County Superior Court) and Ricci v. Archer Daniels
     Midland Co., et al., No. 96-AS-00383 (Filed on February
     6, 1996, Sacramento County Superior Court). As noted
     above, the plaintiffs in these actions and the lysine
     defendants have executed a settlement agreement that has
     been approved by the court and the California Judicial
     Council has bifurcated the citric acid and high fructose
     corn syrup claims and coordinated them with other actions
     in San Francisco County Superior Court and Stanislaus
     County Superior Court.

     SHAREHOLDER DERIVATIVE ACTIONS

     Following the public announcement of the grand jury
     investigation in June 1995, three shareholder derivative
     suits were filed against certain of the Company's then
     current directors and executive officers and nominally
     against the Company in the United States District Court
     for the Northern District of Illinois and fourteen
     similar shareholder derivative suits were filed in the
     Delaware Court of Chancery. The derivative suits filed in
     federal court in Illinois were consolidated under the
     name Felzen, et al. v. Andreas, et al., Civil Action No.
     95-C-4006, 95-C-4535, and a consolidated amended
     derivative complaint was filed on September 29, 1995.
     This complaint names all then current directors of the
     Company (except Mr. Coan) and one former director as
     defendants and names the Company as a nominal defendant.
     It alleges breach of fiduciary duty, waste of corporate
     assets, abuse of control and gross mismanagement, based
     on the antitrust allegations described above, as well as
     other alleged wrongdoing. On October 31, 1995, the Court
     granted the defendants' motion to transfer the Illinois
     consolidated derivative action to the Central District of
     Illinois, wherein it now bears the case number 95-2279.
     On April 26, 1996, the court dismissed the suit without
     prejudice and permitted the plaintiffs twenty-one days to
     refile it. The plaintiffs refiled the complaint on May
     17, 1996. The defendants again moved to dismiss the
     complaint on June 7, 1996.  That motion is currently
     pending.  Plaintiffs have supplemented the complaint to
     include the antitrust settlements and guilty plea
     described above. The fourteen shareholder derivative
     suits filed in the Delaware Court of Chancery have been
     consolidated as In Re Archer Daniels Midland Derivative
     Litigation, Consolidated No. 14403.  An amended and
     consolidated complaint was filed on November 19, 1996.
     ADM moved to dismiss the complaint on December 12, 1996.
     That motion is currently pending.
     19
     PAGE 20
     Item 1.   Legal Proceedings--Continued

     DELAWARE STATE LAW/FEDERAL SECURITIES LAWS ACTIONS

     The Company and its directors also have been named as
     defendants in a putative class action suit encaptioned
     Loudon v. Archer-Daniels-Midland Co., et al., Civil
     Action No. 14638, filed in the Delaware Court of Chancery
     on October 20, 1995. This action alleges violations of
     Delaware state law and seeks invalidation of the 1995
     election of the Company's directors on the basis of
     alleged omissions from the proxy statement issued by the
     Company prior to its October 19, 1995 annual meeting of
     shareholders. The Delaware Court of Chancery dismissed
     this action on February 20, 1996, and the case is now on
     appeal in the Supreme Court of Delaware. The Company and
     its directors also have been named as defendants in a
     similar suit filed on November 1, 1995 in the United
     States District Court for the Central District of
     Illinois, and encaptioned Buckley v. Archer-Daniels-
     Midland Co., et al., Civil Action No. 95-C-2269, alleging
     violations of analogous provisions of federal securities
     law. The defendants moved to dismiss this action. The
     Court granted the motion to dismiss on June 6, 1996, and
     the case is now on appeal.

     As described in the notes to financial statements and
     management's discussion of operations in prior Form 10-
     Q's, the Company has made provisions to cover assessed
     fines, litigation settlements and related costs and
     expenses described above.  However, because of the early
     stage of  other putative class actions described above,
     including those related to high fructose corn syrup, the
     ultimate outcome of these matters cannot presently be
     determined.  Accordingly, no provision for any liability
     that may result therefrom has been made in the
     consolidated financial statements.

     Item 4. Submission of matters to a vote of Security
     Holders:

     The Annual Meeting of Shareholders was held on October
     17, 1996. Proxies for the Annual Meeting were solicited
     pursuant to Regulation 14.  There was no solicitation in
     opposition to the Board of Director nominees as listed in
     the proxy statement and all of such nominees were elected
     as follows:
     20
PAGE 21

<TABLE>
<CAPTION>

Nominee           Shares Cast     Shares
 For                         Withheld
<S>                <C>                <C>
D. O. Andreas     403,996,052         48,693,195
G. O. Coan        405,231,972         47,457,275
L. W. Andreas     403,308,001         49,381,246
S. M. Archer, Jr. 403,949,593         48,739,654
J. K. Vanier      405,020,884         47,668,363
R. R. Burt        409,209,821         43,479,426
O. G. Webb        404,908,866         47,780,381
F. R. Johnson     407,471,039         45,218,208
R. S. Strauss     404,348,243         48,341,004
M. B. Mulroney    404,638,775         48,050,472
J. R. Block       409,166,611         43,522,636
M. H. Carter      405,769,429         46,919,818

There were no abstentions or broker non-votes regarding the
election of directors.


The shareholder proposal relative to the Adoption of an
Incentive Stock Option Plan was ratified as follows:

            For               Against         Abstain

        316,897,743         133,112,790      2,678,714

The shareholder proposal relative to the Adoption of a Stock
Unit Plan for Nonemployee Directors was ratified as follows:

            For               Against         Abstain

        428,385,363         21,489,262       2,814,622

The appointment by the Board of Directors of Ernst & Young LLP
as Independent Accountants to audit the accounts of the
Company for the fiscal year ending June 30, 1997 was ratified
as follows:

            For               Against         Abstain

        448,865,995         2,811,267        1,011,985

The shareholder proposal relative to the Adoption of
Stockholder's Proposal No. 1 (Board Diversity) was defeated as
follows:

            For               Against         Abstain

        68,968,589          291,887,583      13,698,419

The shareholder proposal relative to the Adoption of
Stockholder's Proposal No. 2 (Cumulative Voting) was defeated
as follows:

            For               Against         Abstain

        91,366,745          275,195,548      7,992,298

The shareholder proposal relative to the Adoption of
Stockholder's Proposal No. 3 (Confidential Voting) was
defeated as follows:

            For               Against         Abstain

        167,623,514         199,840,343      7,090,734

The shareholder proposal relative to the Adoption of
Stockholder's Proposal No. 4 (Independent Board) was defeated
as follows:

            For               Against         Abstain

        153,320,313         215,348,980      5,885,298

The shareholder proposal relative to the Adoption of
Stockholder's Proposal No. 5 (Director Liability) was defeated
as follows:

            For               Against         Abstain

        44,913,954          314,568,679      15,071,958
</TABLE>


Item 6. Exhibits and Reports on Form 8-K

a)  Notice of annual meeting and proxy statement dated
September 26, 1996 incorporated as an exhibit herein by
reference.

b)  A Form 8-K was not filed during the quarter ended December
31, 1996.
21
       PAGE 22
                          SIGNATURES

    Pursuant to the requirements of the Securities Act of 1934,
the registrant has duly caused this report to be signed on its
behalf by the undersigned thereunto duly authorized.

                               ARCHER-DANIELS-MIDLAND COMPANY




                                  /s/ D. J. Schmalz
                                  D. J. Schmalz
                                  Vice President
                                  and Chief Financial Officer




                                  /s/ R. P. Reising
                                  R. P. Reising
                                  Vice President, Secretary and
                                  General Counsel



Dated:  February 13, 1997


<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          JUN-30-1997
<PERIOD-END>                               DEC-31-1996
<CASH>                                         337,254
<SECURITIES>                                   555,902
<RECEIVABLES>                                1,306,209
<ALLOWANCES>                                         0
<INVENTORY>                                  2,199,435
<CURRENT-ASSETS>                             4,534,578
<PP&E>                                       8,331,146
<DEPRECIATION>                               4,034,270
<TOTAL-ASSETS>                              11,016,605
<CURRENT-LIABILITIES>                        2,130,577
<BONDS>                                      1,984,735
                                0
                                          0
<COMMON>                                     3,830,125
<OTHER-SE>                                   2,400,107
<TOTAL-LIABILITY-AND-EQUITY>                11,016,605
<SALES>                                      6,937,446
<TOTAL-REVENUES>                             6,937,446
<CGS>                                        6,191,064
<TOTAL-COSTS>                                6,191,064
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              94,260
<INCOME-PRETAX>                                365,897
<INCOME-TAX>                                   172,403
<INCOME-CONTINUING>                            193,494
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   193,494
<EPS-PRIMARY>                                      .36
<EPS-DILUTED>                                      .36
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission